In a single-strand conformation polymorphism (SSCP) analysis, it was revealed that the NBR2 gene shows no mutations in both breast and ovarian cancers, suggesting that the involvement of the NBR2 gene in these cancers is not concerned with gene mutations (46). Here, NBR2 is linked to ovarian carcinoma.